Weil Company’s Clorox CLX Stock Holding History

Weil Company’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-900	Closed	-$137K	–	153
2019 Q3	$137K	Buy	+900	New	+$142K	0.1%	118

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Weil Company's CLX Position: Q4 2019 in Review

Weil Company sold out of Clorox (CLX) in Q4 2019, closing a stake of 900 shares — an estimated $137K sold.

Weil Company first reported a position in CLX in Q3 2019 and held it in 1 quarter. The position peaked at $137K in Q3 2019. 1,030 funds tracked by Wall St. Rank hold CLX as of Q4 2019.

Weil Company reported no remaining Clorox position as of Q4 2019 after selling out during the quarter.
Weil Company sold 900 Clorox shares in Q4 2019, an estimated $137K.
Weil Company first reported a position in Clorox in Q3 2019 and held it in 1 quarter.
Weil Company's Clorox position peaked at $137K in Q3 2019.
1,030 funds tracked by Wall St. Rank held Clorox as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.